enVVeno Medical Corporati...

NASDAQ: NVNO · Real-Time Price · USD
4.64
0.14 (3.11%)
At close: Aug 15, 2025, 2:59 PM

enVVeno Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 812K n/a n/a n/a 824K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
130K n/a 406K n/a 136K 141K 134K 138K 138K 136K 130K n/a 133K 129K 121.59K 120.14K 107.5K 103.68K
Gross Profit
-130K n/a 406K -129K -136K -141K 690K -138K -138K -136K -130K n/a -133K -129K -121.59K -120.14K -107.5K -103.68K
Operating Income
-7.05M -4.95M -6.7M -6.17M -5.45M -5.5M -6.28M -5.35M -6.81M -6.8M -6.46M -6.15M -6.99M -5.33M -8.99M -2.71M -2.39M -2.81M
Interest Income
195K n/a 163K 94K 73K 59K 52K 44K 39K 45K 44K 75K 37K 5K n/a 5K n/a 3K
Pretax Income
-6.69M -4.5M -6.23M -5.64M -4.96M -4.99M -5.65M -5M -6.47M -6.39M -6.18M -6.1M -7.06M -5.33M -8.99M -2.39M -2.38M -2.77M
Net Income
-6.69M -4.5M -6.23M -5.64M -4.96M -4.99M -5.65M -5M -6.47M -5.63M -5.71M -6.1M -7.06M -5.33M -8.99M -2.39M -2.38M -2.77M
Selling & General & Admin
4.03M 2.4M 3.19M 3.31M 2.49M 2.31M 3.16M 2.55M 2.6M 3.2M 3.66M 3.66M 3.91M 3.78M 7.21M 1.48M 1.3M 1.18M
Research & Development
2.89M 2.56M 3.51M 2.86M 2.83M 3.05M 2.98M 2.8M 4.21M 3.6M 2.8M 2.49M 3.07M 1.55M 1.78M 1.22M 1.09M 1.63M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 867.00 32.41K
Operating Expenses
6.92M 4.95M 6.98M 6.17M 5.32M 5.36M 6.14M 5.35M 6.81M 6.8M 6.46M 6.15M 6.99M 5.33M 8.99M 2.71M 2.39M 2.81M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.05M 4.95M 7.38M 6.17M 5.45M 5.5M 6.28M 5.35M 6.81M 6.8M 6.46M 6.15M 6.99M 5.33M 8.99M 2.71M 2.39M 2.81M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -765K -474K -54K n/a n/a n/a n/a -6.7K -2.96K
Shares Outstanding (Basic)
20.35M 20.35M 20.38M 16.07M 16.07M 16.06M 13.32M 11.23M 11.23M 11.23M 9.47M 11.23M 11.23M 11.23M 11.2M 9.18M 8.51M 5.74M
Shares Outstanding (Diluted)
20.35M 20.35M 20.38M 16.07M 16.07M 16.06M 13.32M 11.23M 11.23M 11.23M 9.47M 11.23M 11.23M 11.23M 11.2M 9.18M 8.51M 5.74M
EPS (Basic)
-0.33 -0.22 0.91 -0.35 -0.31 -0.31 -0.42 -0.45 -0.58 -0.5 -0.6 -0.54 -0.63 -0.47 -0.8 -0.26 -0.28 -0.48
EPS (Diluted)
-0.33 -0.22 0.91 -0.35 -0.31 -0.31 -0.42 -0.45 -0.58 -0.5 -0.6 -0.54 -0.63 -0.47 -0.8 -0.26 -0.28 -0.48
EBITDA
-6.56M -4.95M -6.58M -6.04M -5.32M -5.36M -6.14M -5.21M -6.68M -6.66M -6.33M -6.02M -6.85M -5.21M -8.87M -2.71M -2.28M -2.7M
EBIT
-6.69M -4.95M -6.7M -6.17M -5.45M -5.5M -6.28M -5.35M -6.81M -6.8M -6.46M -6.15M -6.99M -5.33M -8.99M -2.71M -2.39M -2.81M
Depreciation & Amortization
130K 122K 122K 129K 136K 141K 134K 138K 138K 136K 130K 133K 133K 129K 121.59K 120.14K 107.5K 103.68K